Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syndrome
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
In this study the investigators aim to compare the efficacy of neomycin to a combination of
rifaximin and neomycin in the treatment of C-IBS subjects with methane on their breath test.
This study will be conducted in collaboration with Dr. John DiBaise at the Mayo Clinic in
Scottsdale, AZ and Dr. Satish Rao in Georgia Regents University in Augusta, GA.
Phase:
N/A
Details
Lead Sponsor:
Mark Pimentel, MD
Collaborators:
Bausch Health Americas, Inc. Valeant Pharmaceuticals International, Inc.